INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 8,890.00
+90.00 (1.02%)
At close: Apr 24, 2026
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 88.76 billion as of April 24, 2026. Its market cap has increased by 21.61% in one year.
Market Cap
88.76B
Enterprise Value
89.03B
Revenue
6.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,890.00
Market Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 88.76B, a decrease of -59.36%. That is a compound annual growth rate of -4.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 87.87B | -16.11% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JS Corporation | 382.44B |
| Hwaseung Enterprise | 282.04B |
| BAIKSAN Co,. | 263.22B |
| Au Brandz Co.,Ltd | 254.03B |
| HWASEUNG Industries | 162.69B |
| Samyang Tongsang | 158.66B |
| 09WOMEN | 127.31B |
| The Nature Holdings | 116.04B |